CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company
Azora Therapeutics, Inc. (DE)
Sign in to watch- Ticker
- AZR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800667150
- Phone
- 434-422-9800
- Business address
- 16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
- Former names
- ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
- 4 Open-market buy 10% owner bought 25,000 shares at $2.60 ($65,000)
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award Chief Development Officer acquired 299,414.43 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Chief Operating Officer acquired 26,510 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 9,185 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 17,325 shares (grant or award)
- 4 Grant or award Director acquired 9,185 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 37,985 shares (grant or award)
- 8-K Event Results of operations
- 10-K Report Annual Report
Page 3 of 30 · 581 filings